| 4MKC: reference: The ALK inhibitor ceritinib overcomes crizotinib resistance in non-small cell lung cancer., Friboulet L, Li N, Katayama R, Lee CC, Gainor JF, Crystal AS, Michellys PY, Awad MM, Yanagitani N, Kim S, Pferdekamper AC, Li J, Kasibhatla S, Sun F, Sun X, Hua S, McNamara P, Mahmood S, Lockerman EL, Fujita N, Nishio M, Harris JL, Shaw AT, Engelman JA, Cancer Discov. 2014 Mar 27. PMID: 24675041 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).